Results 171 to 180 of about 96,357 (264)

Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology. [PDF]

Am J Epidemiol
Conrey SC, Payne DC, Leon MD, Epperson M, Coughlin MM, Burrell AR, Mattison CP, Burke RM, Baker JM, Thornburg NJ, McMorrow ML, Staat MA, Morrow AL.   +12 more
europepmc   +1 more source

Respiratory syncytial virus infections - recent developments providing promising new tools for disease prevention. [PDF]

Euro Surveill, 2023
Broberg EK, Nohynek H.
europepmc   +1 more source

Climate change and the end of the respiratory syncytial virus season [PDF]

, 2006
Donaldson, GC
core   +1 more source

Genetic and Epidemiological Insights Into Respiratory Syncytial Virus Infections: A Comparative Study of Hospitalized Versus Community Cases in Portugal (2021-2023). [PDF]

Influenza Other Respir Viruses
Lança M, Gaio V, Rodrigues AP, Henriques C, Gomes L, Dias D, de Jesus Chasqueira M, Guiomar R, Melo A.   +8 more
europepmc   +1 more source

Estimated Incidence of All-Cause Respiratory Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Finland between 2011 and 2019: A Retrospective Database Study. [PDF]

J Epidemiol Glob Health
Bruyndonckx R, Polkowska-Kramek A, Liang C, Kosunen M, Hätinen OP, Esnaola M, Casas M, Peerawaranun P, Ewnetu WB, Gessner BD, Begier E.   +10 more
europepmc   +1 more source

Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect. [PDF]

Front Cell Infect Microbiol
Xia Z, Li X, Shen A, Mokrousov I, Guo P, Zhang Y.   +5 more
europepmc   +1 more source

Clinical progression parameters associated with SARS-CoV-2, influenza, and respiratory syncytial virus infections in a large US integrated healthcare population. [PDF]

PLoS Comput Biol
Parker NT, Hong V, Davis GS, Pomichowski M, Reyes IA, Xie F, Mueller NF, Rodriguez-Barraquer I, Tartof SY, Lewnard JA.   +9 more
europepmc   +1 more source

Global outbreaks of respiratory syncytial virus infections from 1960 to 2025: a systematic review and meta-analysis. [PDF]

EClinicalMedicine
Duan Q, Pan J, Zheng L, Jin Z, Li S, Zhang H, Fu X, Chen R, Yu Z, Qin S, Xu X, Chen Y, Sun J, Liu S.   +13 more
europepmc   +1 more source

Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections. [PDF]

Hum Vaccin Immunother, 2023
Weil-Olivier C, Salisbury D, Navarro-Alonso JA, Tzialla C, Zhang Y, Esposito S, Midulla F, Tenenbaum T.   +7 more
europepmc   +1 more source

Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. [PDF]

NPJ Vaccines
Taquet M, Todd JA, Harrison PJ.
europepmc   +1 more source